IMPACT OF A SWITCH FROM DUAL ANTIPLATELET THERAPY TO SINGLE ANTIPLATELET THERAPY IN DIABETES AND NON-DIABETES POST ACS: INSIGHTS FROM THE EPICOR AND EPICOR-ASIA STUDIES

IMPACT OF A SWITCH FROM DUAL ANTIPLATELET THERAPY TO SINGLE ANTIPLATELET THERAPY IN DIABETES AND NON-DIABETES POST ACS: INSIGHTS FROM THE EPICOR AND EPICOR-ASIA STUDIES

Methods: EPICOR (long-tErm follow-uP of anti-thrombotic management patterns In acute CORonary syndrome patients, NCT01171404) and EPICOR Asia (NCT01361386) are prospective, observational studies in 23,489 surviving ACS patients with 2-y follow up from 28 countries in Asia, Europe and Latin America.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.110-110
Hauptverfasser: Van de Werf, Frans J.J, Han, Yaling, Rossello, Xavier, Huo, Yong, Pocock, Stuart J, Li, Yi, Jiang, Jie, Vega, Ana Maria, Medina, Jesús, Bueno, Héctor
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Cardiology
Cardiovascular
Diabetes
Internal Medicine
Studies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods: EPICOR (long-tErm follow-uP of anti-thrombotic management patterns In acute CORonary syndrome patients, NCT01171404) and EPICOR Asia (NCT01361386) are prospective, observational studies in 23,489 surviving ACS patients with 2-y follow up from 28 countries in Asia, Europe and Latin America.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)33499-X